- QMRO Home
- Barts Cancer Institute
- Centre for Molecular Oncology
- Phase 1 dose-expansion study of pegylated arginine deiminase, cisplatin, and pemetrexed in patients with argininosuccinate synthetase 1 (ASS1)-deficient non-squamous non-small cell lung cancer.
Browse
Administrators only